Regeneron (REGN) Reports Positive 2-Yr Results from Phase 3 PANORAMA Trial Evaluating EYLEA (aflibercept) Injection 2mg

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. ASML
2. USO
3. LAD
4. ROIV
5. DKNG
6. BSX
7. ODFL
8. NVS
9. AHR
10. ALV

Go back to Regeneron (REGN) Reports Positive 2-Yr Results from Phase 3 PANORAMA Trial Evaluating EYLEA (aflibercept) Injection 2mg
Regeneron (NASDAQ: REGN) Delayed: 827.72 --0 (-0%)
Previous Close $827.72    52 Week High $592.36 
Open $827.72    52 Week Low $325.35 
Day High $827.72    P/E 217.25 
Day Low $827.72    EPS $3.81 
Volume 155